Evidence map›Paper›PMID 42079459›Full record

ArticleClinical kidney journal2026

Frailty assessment in kidney transplantation: insights from a European survey.

Arzu Velioglu, Helen Erlandsson, Erol Demir, Rachel Hellemans, Ilaria Gandolfini, Annelis de Weerd, Ivana Dedinska, Adnan Sharif, Mario Schiffer, Luuk Hilbrands and 1 more

Abstract read
In one paragraph

Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Arzu VeliogluDepartment of Nephrology, Marmara University School of Medicine, Istanbul, Türkiye.ORCID https://orcid.org/0000-0001-9750-7585
Helen ErlandssonDepartment of Clinical Science, Intervention and Technology, Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-3898-2575
Erol DemirTransplant Immunology Research Centre of Excellence, Koç University Hospital, Istanbul, Türkiye.ORCID https://orcid.org/0000-0003-0128-5645
Rachel HellemansDepartment of Nephrology-Hypertension, Antwerp University Hospital, Edegem, Belgium.
Ilaria GandolfiniNephrology Unit, University Hospital of Parma, Parma, Italy.ORCID https://orcid.org/0000-0002-0485-851X
Annelis de WeerdDepartment of Internal Medicine, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Ivana DedinskaTransplant-Nephrology Department, Jessenius Faculty of Medicine, Comenius University and University Hospital Martin, Martin, Slovakia.ORCID https://orcid.org/0000-0002-8246-4268
Adnan SharifDepartment of Nephrology and Transplantation, University Hospitals Birmingham, Queen Elizabeth Hospital, Birmingham, UK.ORCID https://orcid.org/0000-0002-7586-9136
Mario SchifferDepartment of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Luuk HilbrandsDepartment of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID https://orcid.org/0000-0002-4935-9765
Christophe MariatService de Néphrologie, Dialyse et Transplantation Rénale, Hôpital Nord, CHU de Saint-Etienne, Université Jean Monnet, Saint-Etienne, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Frailty has been identified as an important determinant of adverse transplant-related outcomes; however, its integration into routine kidney transplant practice remains limited. Methods: This was a web-based cross-sectional survey assessing current practice patterns and perceptions on frailty assessments among transplant physicians distributed by the DESCaRTES working group of the European Renal Association. The survey consisted of questions about frailty perceptions and practices both pre- and post-transplant. Results: A total of 134 responses (response rate 39.2%) were recorded. Although 98.5% recognized frailty as a risk factor for adverse outcomes, only 6.7% reported routinely performing a standardized frailty assessment in pre-transplant evaluations. Nearly 30% never evaluated frailty, and 24.6% did so only in selected high-risk patients, primarily based on age, comorbidities or prolonged dialysis duration. Physical function was recognized as the most important component of frailty assessments; however, no single assessment tool was consistently implemented. The main barriers to integrating frailty assessments into clinical practice were lack of trained staff, absence of standardized guidelines, and uncertainty about clinical usefulness. Post-transplant frailty assessments were rarely conducted routinely, despite 74.6% acknowledging their potential value. Conclusions: Despite widespread recognition of frailty as a significant determinant influencing transplant outcomes, its routine assessment in clinical practice remains limited across European centers. Variability in assessment tools, lack of guidelines and insufficient training resources contribute to this gap. Addressing these barriers through targeted education, validation of practical assessment tools, and consensus-driven protocols is essential to support the integration of frailty evaluation into both pre- and post-transplant care.

Indexed as

frailtykidney transplantationoutcomescreeningsurvey

Identifiers

PMID42079459
PMCPMC13133629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.